David C. Henshall

14.6k total citations · 1 hit paper
244 papers, 11.0k citations indexed

About

David C. Henshall is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cancer Research. According to data from OpenAlex, David C. Henshall has authored 244 papers receiving a total of 11.0k indexed citations (citations by other indexed papers that have themselves been cited), including 163 papers in Molecular Biology, 91 papers in Cellular and Molecular Neuroscience and 67 papers in Cancer Research. Recurrent topics in David C. Henshall's work include Neuroscience and Neuropharmacology Research (83 papers), MicroRNA in disease regulation (64 papers) and Cell death mechanisms and regulation (38 papers). David C. Henshall is often cited by papers focused on Neuroscience and Neuropharmacology Research (83 papers), MicroRNA in disease regulation (64 papers) and Cell death mechanisms and regulation (38 papers). David C. Henshall collaborates with scholars based in Ireland, United States and Japan. David C. Henshall's co-authors include Roger P. Simon, Tobías Engel, Eva M. Jiménez‐Mateos, Jochen H.M. Prehn, Robert Meller, Clara K. Schindler, Gary P. Brennan, Waro Taki, Xiao Mao and Lin Xie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

David C. Henshall

236 papers receiving 10.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased hippocampal neurogenesis in Alzheimer's disease

2003 809 citations David C. Henshall et al. profile →

Peers

Countries citing papers authored by David C. Henshall

Since Specialization

Citations

This map shows the geographic impact of David C. Henshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Henshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Henshall more than expected).

Fields of papers citing papers by David C. Henshall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Henshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Henshall. The network helps show where David C. Henshall may publish in the future.

Co-authorship network of co-authors of David C. Henshall

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Henshall. A scholar is included among the top collaborators of David C. Henshall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Henshall. David C. Henshall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Restoration of blood brain barrier integrity post neurosurgical resection in drug resistant epilepsy 2025 ·Epilepsy & Behavior ·(unknown), Chris Greene, Nicole Hanley, Charitini Salla, (unknown), Ruairi Connolly, Kieron J. Sweeney, (unknown), Michael Farrell, James F. Meaney, David C. Henshall, Matthew Campbell, Colin P. Doherty	2
2	Temporal Dynamics of tsRNA Regulation Mark an Abrupt Transition After Epileptogenesis 2025 ·Journal of Neurochemistry ·(unknown), (unknown), Niamh M. C. Connolly, Kai Siebenbrodt, Sebastian Bauer, Felix Rosenow, Jens Andersen, Morten T. Venø, Jørgen Kjems, David C. Henshall, Jochen H.M. Prehn	0
3	The role of electroencephalography in epilepsy research—From seizures to interictal activity and comorbidities 2025 ·Epilepsia ·(unknown), Liset Menéndez de la Prida, Edward H. Bertram, Mark O. Cunningham, David C. Henshall, Anli Liu, Vadym Gnatkovsky, Simona Balestrini, Marco de Curtis, Aristea S. Galanopoulou, Julia Jacobs, John G. R. Jefferys, Massimo Mantegazza, Cristina R. Reschke, Přemysl Jiruška	4
4	Altered Short Non-Coding RNA Landscape in the Hippocampus of a Mouse Model of CDKL5 Deficiency Disorder 2025 ·Biomolecules ·(unknown), (unknown), (unknown), (unknown), (unknown), Elena Langa, (unknown), Morten T. Venø, (unknown), David C. Henshall, Omar Mamad	0
5	WONOEP appraisal: Modeling early onset epilepsies 2024 ·Epilepsia ·(unknown), Christopher A. Reid, Stéphane Auvin, Peter L. Carlen, Andrew J. Cole, (unknown), (unknown), Solomon L. Moshé, Raman Sankar, Terence J. O’Brien, Stéphanie Baulac, David C. Henshall, Özlem Akman, Aristea S. Galanopoulou	0
6	Pumilio-1 mediated translational control of claudin-5 at the blood-brain barrier 2024 ·Fluids and Barriers of the CNS ·Yosuke Hashimoto, Chris Greene, Nicole Hanley, Natalie Hudson, David C. Henshall, Kieron J. Sweeney, Donncha F. O’Brien, Matthew Campbell	2
7	WONOEP 2022: Neurotechnology for the diagnosis of epilepsy 2024 ·Epilepsia ·Konrad Wagstyl, Katja Kobow, Pablo M. Casillas‐Espinosa, Andrew J. Cole, Diego Jiménez‐Jiménez, Hiroki Nariai, Stéphanie Baulac, Terence J. O’Brien, David C. Henshall, Özlem Akman, Raman Sankar, Aristea S. Galanopoulou, Stéphane Auvin	3
8	MicroRNA inhibition using antimiRs in acute human brain tissue sections 2022 ·Epilepsia ·Gareth Morris, Elena Langa, Conor Fearon, (unknown), (unknown), Amaya Sanz‐Rodriguez, Donncha F. O’Brien, Kieron J. Sweeney, L.G. Austin, Norman Delanty, (unknown), Francesca Brett, Jane Cryan, Mark O. Cunningham, David C. Henshall	6
9	AntimiR targeting of microRNA-134 reduces seizures in a mouse model of Angelman syndrome 2022 ·Molecular Therapy — Nucleic Acids ·(unknown), Gareth Morris, Albert Sanfeliu, (unknown), Elena Langa, Jaideep Kesavan, Thanh Ngoc Nguyen, Ronán Conroy, Jesper Worm, (unknown), Mads A. Jensen, Meghan T. Miller, Thomas Kremer, Cristina R. Reschke, David C. Henshall	16
10	Microvascular stabilization via blood-brain barrier regulation prevents seizure activity 2022 ·Nature Communications ·Chris Greene, Nicole Hanley, Cristina R. Reschke, (unknown), Maarja Andaloussi Mäe, Ruairi Connolly, (unknown), Eoin O’Keeffe, (unknown), Natalie Hudson, Conor P. Delaney, Michael A. Farrell, Donncha F. O’Brien, Jane Cryan, Francesca Brett, (unknown), Christer Betsholtz, David C. Henshall, Colin P. Doherty, Matthew Campbell	101
11	Increased expression of the ATP‐gated P2X7 receptor reduces responsiveness to anti‐convulsants during status epilepticus in mice 2021 ·British Journal of Pharmacology ·Edward Beamer, James J. Morgan, Mariana Alves, (unknown), Gareth Morris, (unknown), Giorgia Conte, Laura de Diego-García, Cristina Alarcón‐Vila, (unknown), Stephen F. Madden, (unknown), Cristóbal de los Rı́os, Antonio G. Garcı́a, Michael Hamacher, Klaus Dinkel, Pablo Pelegrı́n, David C. Henshall, Annette Nicke, Tobías Engel	27
12	CHD2-Related CNS Pathologies 2021 ·International Journal of Molecular Sciences ·(unknown), David C. Henshall, Susan Byrne, Gary P. Brennan	22
13	High concordance between hippocampal transcriptome of the mouse intra‐amygdala kainic acid model and human temporal lobe epilepsy 2020 ·Epilepsia ·Giorgia Conte, Alberto Parras, (unknown), (unknown), Laura de Diego-García, Edward Beamer, Razi Alalqam, Alejandro Ocampo, Raúl Méndez, David C. Henshall, José J. Lucas, Tobías Engel	24
14	Epilepsy Benchmarks Area III: Improved Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects 2020 ·Epiliepsy currents ·Stephen F. Traynelis, Dennis Dlugos, David C. Henshall, Heather C. Mefford, Michael A. Rogawski, Kevin J. Staley, Penny A. Dacks, Vicky Whittemore, Annapurna Poduri	8
15	Neuroinflammatory targets and treatments for epilepsy validated in experimental models 2017 ·Epilepsia ·Eleonora Aronica, Sebastian Bauer, Yuri Bozzi, Matteo Caleo, Raymond Dingledine, Jan A. Gorter, David C. Henshall, Daniela Kaufer, Sookyong Koh, Wolfgang Löscher, Jean‐Pierre Louboutin, Michele Mishto, Braxton A. Norwood, Eleonora Palma, Michael O. Poulter, Gaetano Terrone, Annamaria Vezzani, Rafał M. Kamiński	151
16	CHOP regulates the p53–MDM2 axis and is required for neuronal survival after seizures 2013 ·Brain ·Tobías Engel, (unknown), Eva M. Jiménez‐Mateos, Caoimhín G. Concannon, Alba Jimenez‐Pacheco, Catherine Moran, Guillaume Mesuret, Emilie Petit, Norman Delanty, Michael A. Farrell, Donncha F. O’Brien, Jochen H.M. Prehn, José J. Lucas, David C. Henshall	77
17	Differential DNA Methylation Patterns Define Status Epilepticus and Epileptic Tolerance 2012 ·Journal of Neuroscience ·Suzanne F. C. Miller-Delaney, Sudipto Das, Takanori Sano, Eva M. Jiménez‐Mateos, Kenneth Bryan, Patrick G. Buckley, Raymond L. Stallings, David C. Henshall	87
18	Identification of a Novel Bcl-2-interacting Mediator of Cell Death (Bim) E3 Ligase, Tripartite Motif-containing Protein 2 (TRIM2), and Its Role in Rapid Ischemic Tolerance-induced Neuroprotection 2011 ·Journal of Biological Chemistry ·Simon Thompson, (unknown), Michelle D. Ashley, (unknown), Brona M. Murphy, Philip R. Gafken, David C. Henshall, (unknown), Roger P. Simon, Robert Meller	50
19	Seizure preconditioning and epileptic tolerance: models and mechanisms. 2009 ·PubMed Central ·Eva M. Jiménez‐Mateos, David C. Henshall	26
20	Development of a model of seizure‐induced hippocampal injury with features of programmed cell death in the BALB/c mouse 2004 ·Journal of Neuroscience Research ·Sachiko Shinoda, Tomohiro Araki, Jing‐Quan Lan, Clara K. Schindler, Roger P. Simon, Waro Taki, David C. Henshall	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact